Managing an unplanned gap in supply — what changed since

Resuming after a gap: after a gap of days or a few weeks, most people resume at the dose they were on when they stopped. Gaps of months might require retitration discussion with a clinician.

A single observation, in a thread that deserves better than single observations.

Supply interruptions: official shortage notices are published by regulatory agencies. That is the correct primary source rather than pharmacy rumors or forum discussion.

That is the shape of it. The detail is where I would expect to be corrected.

Answering the question post #29 raises rather than the one it answers.

Stockpiling in response to a shortage worsens it, which is true and is a poor argument to make to somebody who has run out.

This follows post #37 rather than contradicting it.

Reports that a pharmacy has stock are the least durable information on the site and are still worth posting with a date.

Where a manufacturer publishes a supply statement, that document is more reliable than any aggregation of individual experiences.

I keep a log for Managing an unplanned gap specifically because my memory of it turned out to be systematically wrong in one direction. Six weeks of notes cost nothing and settled it.

I had written a reply contradicting post #80 and deleted it. Here is what survived.

The published shortage register maintained by the national regulator is the authoritative source here, and it is updated far more often than any thread.

I have left out the parts I could not verify.

Nothing to add on the substance. Thank you for taking the question at face value.

Post #91 is right about the mechanism and I think understates the practical bit.

Communication from suppliers: a supplier having supply problems usually communicates them. If a supplier goes silent, that is itself information.